Elekta AB

Equities

EKTA B

SE0000163628

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 11:29:34 2024-04-26 am EDT			5-day change	1st Jan Change
75.6 ^SEK	+2.30%		+1.54%	-8.16%

Apr. 22	Elekta, GE HealthCare Team Up for New Cancer Treatment Planning Services	MT
Apr. 22	Elekta and MIM Software Inc. Announce Collaboration to Combine Best-Of-Breed Solutions for Advanced Treatment Planning in the Delivery of Radiation Therapy	CI

100th Elekta Unity MR-Linac of Elekta AB Goes to St George's Hospital in New Zealand

June 01, 2021 at 01:30 am EDT

Elekta (EKTA-B.ST) announced that St George's Hospital in Christchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th device sold since introduction. The innovative radiation therapy device is found in 14 countries across five continents.

Latest news about Elekta AB

Elekta, GE HealthCare Team Up for New Cancer Treatment Planning Services	Apr. 22	MT
Elekta and MIM Software Inc. Announce Collaboration to Combine Best-Of-Breed Solutions for Advanced Treatment Planning in the Delivery of Radiation Therapy	Apr. 22	CI
ELEKTA : Elekta’s attractiveness reinforced	Mar. 06
Elekta AB Announces Resignation of Kelly Londy, Member of the Board	Mar. 01	CI
ELEKTA : Q3 miss; mid-to-longer term prospects remain promising	Mar. 01
Transcript : Elekta AB, Q3 2024 Earnings Call, Feb 29, 2024	Feb. 29
Elekta AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Feb. 29	CI
Nordic Stocks Closed Down Wednesday; Sinch Took Biggest Hit	Jan. 03	DJ
Nordic Shares Decreased Tuesday; Sinch Took Biggest Hit	Jan. 02	DJ
Elekta and Bristol Myers Squibb Partner on Digital Solution for Patients with Melanoma	Dec. 19	CI
Elekta, Bristol Myers Squibb Collaborate on Digital Platform for Melanoma Patients	Dec. 19	MT
Nordic Shares Closed Up Thursday; Autostore Holdings Topped Leaders	Nov. 30	DJ
ELEKTA : Another quarterly beat; but market disappointment with the Q3 outlook	Nov. 30
European shares scale 2-mth high on energy, financial boost; eye strong monthly gains	Nov. 30	RE
Transcript : Elekta AB, Q2 2024 Earnings Call, Nov 30, 2023	Nov. 30
Elekta AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Nov. 30	CI
Elekta Receives Order for Approximately USD 40 Million from KIMS Hyderabad	Nov. 07	CI
Elekta AB Announces Composition of Nomination Committee	23-10-31	CI
Elekta Enters $5.5 Million Deal to Acquire iCAD's Xoft Business	23-10-23	MT
Elekta AB (OM:EKTA B) acquired Xoft, Inc. from iCAD, Inc. for $5.8 million.	23-10-22	CI
Nordic Shares Closed Up Wednesday; ALK-Abello Series B Led Increases	23-10-04	DJ
Chinese headwinds could be more severe than expected	23-09-22
ELEKTA : Taking into account possible challenges due to China's corruption crackdown	23-09-14
Elekta, International Atomic Energy Agency Enter Partnership to Boost Cancer Care in Underserved Countries	23-08-29	MT
Elekta and the International Atomic Energy Agency Partner to Improve Access to Cancer Care in Underserved Countries	23-08-29	CI

Chart Elekta AB

Duration

Period

More charts

Company Profile

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-04 - Q4 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ELEKTA : Elekta’s attractiveness reinforced

March 06, 2024 at 11:06 am EST

More Strategies

Ratings for Elekta AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

75.6 SEK

Average target price

83.42 SEK

Spread / Average Target

+10.34%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ELEKTA AB	-8.16%	2.59B
THERMO FISHER SCIENTIFIC	+8.07%	218B
DANAHER CORPORATION	+6.59%	182B
INTUITIVE SURGICAL, INC.	+11.26%	132B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.98B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	47.59B
AGILENT TECHNOLOGIES, INC.	-0.93%	39.96B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.22B
RESMED, INC.	+26.76%	26.94B

Other Advanced Medical Equipment & Technology